{"id":"https://openalex.org/W2090786403","doi":"https://doi.org/10.1016/s0960-894x(00)00097-4","title":"Isoxazolines and isoxazoles as factor Xa inhibitors","display_name":"Isoxazolines and isoxazoles as factor Xa inhibitors","publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W2090786403","doi":"https://doi.org/10.1016/s0960-894x(00)00097-4","mag":"2090786403","pmid":"https://pubmed.ncbi.nlm.nih.gov/10782664"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(00)00097-4","doi":"https://doi.org/10.1016/s0960-894x(00)00097-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(00)00097-4","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082976193","display_name":"James R. Pruitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James R Pruitt","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, Wilmington, Delaware 19880-0500, USA. james.r.pruitt@dupontpharma.com","The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, Wilmington, Delaware 19880-0500, USA. james.r.pruitt@dupontpharma.com","institution_ids":["https://openalex.org/I1316910977"]},{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062012797","display_name":"Donald J. P. Pinto","orcid":"https://orcid.org/0000-0003-4356-5979","observed_orcids":["https://orcid.org/0000-0003-4356-5979"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald J Pinto","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061333167","display_name":"Melissa Estrella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa J Estrella","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033292728","display_name":"Lori L. Bostrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori L Bostrom","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084860922","display_name":"Robert M. Knabb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M Knabb","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026904604","display_name":"Pancras C. Wong","orcid":"https://orcid.org/0000-0002-8224-7423","observed_orcids":["https://orcid.org/0000-0002-8224-7423"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pancras C Wong","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055584694","display_name":"Matthew R. Wright","orcid":"https://orcid.org/0000-0002-6787-8104","observed_orcids":["https://orcid.org/0000-0002-6787-8104"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew R Wright","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003421053","display_name":"Ruth R. Wexler","orcid":"https://orcid.org/0000-0001-5514-5053","observed_orcids":["https://orcid.org/0000-0001-5514-5053"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth R Wexler","raw_affiliation_strings":["The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The DuPont Pharmaceuticals Company, PO Box 80500, Wilmington, Delaware 19880-0500, USA","institution_ids":["https://openalex.org/I1316910977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5082976193"],"corresponding_institution_ids":["https://openalex.org/I1316910977"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":2.3045,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.88083809,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":"8","first_page":"685","last_page":"689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.042899999767541885,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isoxazolines","display_name":"isoxazolines","score":0.9919999837875366},{"id":"https://openalex.org/keywords/isoxazoles","display_name":"isoxazoles","score":1.0},{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antithrombotic-agents","display_name":"antithrombotic agents","score":0.8650000095367432},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.75}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9447022676467896},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.817874550819397},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.8106892108917236},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7327609062194824},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.6347579956054688},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5569643974304199},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.49345913529396057},{"id":"https://openalex.org/C2778622868","wikidata":"https://www.wikidata.org/wiki/Q423088","display_name":"Amidine","level":2,"score":0.4615585505962372},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45488241314888},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3666079044342041},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27304327487945557},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09074026346206665},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0960-894x(00)00097-4","doi":"https://doi.org/10.1016/s0960-894x(00)00097-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(00)00097-4","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:10782664","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10782664","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1543881406","https://openalex.org/W1973054980","https://openalex.org/W1985407614","https://openalex.org/W2006194634","https://openalex.org/W2032028280","https://openalex.org/W2042935486","https://openalex.org/W2049527791","https://openalex.org/W2052512977","https://openalex.org/W2083840022","https://openalex.org/W2266048773","https://openalex.org/W2344072686","https://openalex.org/W2411350820","https://openalex.org/W2950598752","https://openalex.org/W4234761044","https://openalex.org/W4240397901","https://openalex.org/W4245294341"],"related_works":["https://openalex.org/W2006194634","https://openalex.org/W4240397901","https://openalex.org/W7167275743","https://openalex.org/W2046990628","https://openalex.org/W2950271520","https://openalex.org/W2003325869","https://openalex.org/W2952912485","https://openalex.org/W2521991703","https://openalex.org/W4247745215","https://openalex.org/W2066673831"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}